A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
Last weekend marked the 59th Annual Meeting of the American Society of Hematology or ASH.…
ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech…
Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T…
Gilead's CAR-T cell therapy Yescarta has been approved by the FDA, making it the first…
ADC Therapeutics has presented preliminary Phase I data in lymphoma patients suggesting its ADC technology…
Innate Pharma has released the safety and efficacy results of a Phase I trial testing…
Update (02/06/2017): MorphoSys has successfully completed Phase II with MOR208 in combination with bendamustine and…
The FDA just granted Bayer priority review for copanlisib, a PI3K inhibitor which could be…
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
Janssen and Genmab will not proceed to evaluate daratumumab as a treatment for non-Hodgkin's lymphoma since it…
Actelion has received approval from the European Commission for Ledaga, a treatment to prevent the…